HRT Financial’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-86,085
Closed -$3.58M – 3916
2025
Q4
$3.58M Buy
86,085
+48,287
+128% +$1.96M 0.01% 951
2025
Q3
$1.74M Buy
+37,798
New +$2.02M 0.01% 1214
2025
Q1
– Sell
-11,140
Closed -$482K – 2621
2024
Q4
$482K Buy
+11,140
New +$495K ﹤0.01% 1458
2024
Q2
– Sell
-20,424
Closed -$1.35M – 2332
2024
Q1
$1.35M Buy
+20,424
New +$1.66M 0.01% 743
2023
Q3
– Sell
-12,831
Closed -$1.04M – 2477
2023
Q2
$1.04M Buy
+12,831
New +$1.2M 0.01% 930
2022
Q4
– Sell
-39,625
Closed -$4.42M – 2557
2022
Q3
$4.42M Buy
+39,625
New +$5.07M 0.05% 323
2022
Q1
– Sell
-6,513
Closed -$1.16M – 3207
2021
Q4
$1.16M Buy
6,513
+3,808
+141% +$679K 0.01% 994
2021
Q3
$478K Sell
2,705
-75,406
-97% -$12.5M ﹤0.01% 2037
2021
Q2
$12.6M Buy
+78,111
New +$12M 0.12% 157

Other funds holding CNXC

HRT Financial's CNXC Position: Q1 2026 in Review

HRT Financial sold out of Concentrix (CNXC) in Q1 2026, closing a stake of 86,085 shares — an estimated $3.58M sold.

HRT Financial first reported a position in CNXC in Q2 2021 and held it in 9 quarters. The position peaked at $12.6M in Q2 2021. 304 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

  • HRT Financial reported no remaining Concentrix position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 86,085 Concentrix shares in Q1 2026, an estimated $3.58M.
  • HRT Financial first reported a position in Concentrix in Q2 2021 and held it in 9 quarters.
  • HRT Financial's Concentrix position peaked at $12.6M in Q2 2021.
  • 304 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.